Right-sided heart failure is attributed to prolonged high blood pressure in the lung’s arteries and the heart’s right ventricles leading to heart failure. The symptoms of right-sided heart failure include shortness of breath when carrying out activities and a quick heartbeat. Over time, other symptoms that may occur include swelling of the ankles or feet, cyanosis, fainting episodes during activity, chest pain, chest discomfort, and signs of lung disorders such as coughing or wheezing (Rosenkranz et al., 2020). Regarding treatment, appropriate treatment for right-sided heart failure is based on the underlying issue causing it. The treatment of right-sided heart failure often entails the utilization of one or more drugs such as pulmonary vasodilators, diuretics, vasodilators, digoxin, and beta-blockers. Other treatment options include lifestyle measures, and potentially implanted devices to support the heart to pump blood.
Left-sided heart failure occurs when the left ventricle is forced to pump blood harder than normal to provide sufficient blood to maintain a healthy body. This condition is more common than right-sided heart failure. The symptoms of left-sided heart failure include shortness of breath, coughing, difficulty breathing, difficulty breathing during physical activity, and shortness of breath during sleep (Axelsson Raja et al., 2020). The treatment of left-sided heart failure involves various options. The best option depends on whether the problem is systolic heart failure or diastolic heart failure. The treatment often entails medications, surgery and other procedures, and lifestyle changes. The medications intervention often include digoxin to control heart rate, beta-blockers to reduce heart rates and regulate heart function, Sodium-glucose transport protein 2 (SGLT2) inhibitors to reduce excess fluid, water pills to help the body eliminate excess fluid, and Angiotensin-receptor neprilysin inhibitors (ARNIs) to remodel heart and relax blood vessels.
References
Axelsson Raja, A., Warming, P. E., Nielsen, T. L., Plesner, L. L., Ersbøll, M., Dalsgaard, M., … & Iversen, K. (2020). Left-sided heart disease and risk of death in patients with end-stage kidney disease receiving haemodialysis: an observational study. BMC nephrology, 21(1), 1-9. https://doi.org/10.1186/s12882-020-02074-3
Rosenkranz, S., Howard, L. S., Gomberg-Maitland, M., & Hoeper, M. M. (2020). Systemic consequences of pulmonary hypertension and right-sided heart failure. Circulation, 141(8), 678-693. https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.116.022362
Order this paper